Previous Article | Next Article 
Antimicrob Agents Chemother. 1987 January; 31(1): 32-36
Inoculum effect with chloroquine and Plasmodium falciparum.
I Y Gluzman,
P H Schlesinger and
D J Krogstad
ABSTRACT
In the studies reported here, we examined the inoculum effect observed with chloroquine and Plasmodium falciparum. The 50% effective doses observed with both chloroquine-susceptible and -resistant parasites increased five- to sevenfold from their baseline values as the inoculum was increased from 2 X 10(5) to 2 X 10(7) parasitized erythrocytes per ml (parasitemias of 0.1 to 10% with a hematocrit of 2%). Increasing the inoculum also decreased the chloroquine uptake per parasitized erythrocyte 15- to 20-fold with both chloroquine-susceptible and -resistant parasites. However, because of the 100-fold increase in the inoculum, the total amount of chloroquine taken up actually increased sufficiently to reduce the extracellular chloroquine concentration in vitro by 60 to 90%. These studies suggest that a chloroquine uptake of greater than or equal to 2.0 pmol/10(6) parasitized erythrocytes is necessary for chloroquine to inhibit parasite growth. More marked reductions in the amount of chloroquine uptake per parasitized erythrocyte were observed with a hematocrit of 40% using similar parasitemias of 0.1 to 10% (inocula of 4 X 10(6) to 4 X 10(8) parasitized erythrocytes per ml). Thin-layer chromatography of [3H]chloroquine taken up by chloroquine-resistant P. falciparum revealed no evidence of drug alteration by the parasite. These studies define the mechanism responsible for the inoculum effect observed with chloroquine and P. falciparum in vitro.
Antimicrob Agents Chemother. 1987 January; 31(1): 32-36
This article has been cited by other articles:
-
Niles, J. C., DeRisi, J. L., Marletta, M. A.
(2009). Inhibiting Plasmodium falciparum growth and heme detoxification pathway using heme-binding DNA aptamers. Proc. Natl. Acad. Sci. USA
106: 13266-13271
[Abstract]
[Full Text]
-
Hasugian, A. R., Tjitra, E., Ratcliff, A., Siswantoro, H., Kenangalem, E., Wuwung, R. M., Purba, H. L. E., Piera, K. A., Chalfien, F., Marfurt, J., Penttinen, P. M., Russell, B., Anstey, N. M., Price, R. N.
(2009). In Vivo and In Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium vivax. Antimicrob. Agents Chemother.
53: 1094-1099
[Abstract]
[Full Text]
-
KREIDENWEISS, A., KREMSNER, P. G., DIETZ, K., MORDMULLER, B.
(2006). IN VITRO ACTIVITY OF FERROQUINE (SAR97193) IS INDEPENDENT OF CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUM. Am J Trop Med Hyg
75: 1178-1181
[Abstract]
[Full Text]
-
Kreidenweiss, A., Mordmuller, B., Krishna, S., Kremsner, P. G.
(2006). Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon.. Antimicrob. Agents Chemother.
50: 1535-1537
[Abstract]
[Full Text]
-
KONGTHAISONG, M., NA-BANGCHANG, K., MUNGTHIN, M., SINCHAIPANID, N., TAN-ARIYA, P.
(2004). COMPARISON OF THE BIOEQUIVALENCE OF THREE ORAL FORMULATIONS OF DIHYDROARTEMISININ BASED ON EX VIVO BLOOD SCHIZONTOCIDAL ACTIVITIES AGAINST PLASMODIUM FALCIPARUM. Am J Trop Med Hyg
71: 703-710
[Abstract]
[Full Text]
-
BASCO, L. K.
(2004). MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XX. EXPERIMENTAL STUDIES ON VARIOUS FACTORS OF IN VITRO DRUG SENSITIVITY ASSAYS USING FRESH ISOLATES OF PLASMODIUM FALCIPARUM. Am J Trop Med Hyg
70: 474-480
[Abstract]
[Full Text]
-
Martiney, J. A., Cerami, A., Slater, A. F. G.
(1995). Verapamil Reversal of Chloroquine Resistance in the Malaria Parasite Plasmodium falciparum Is Specific for Resistant Parasites and Independent of the Weak Base Effect. J. Biol. Chem.
270: 22393-22398
[Abstract]
[Full Text]